Topical lidocaine reduces pain in post-herpetic neuralgia.

Pain
M C Rowbotham, H L Fields

Abstract

We report the results of a single session, non-blinded, trial of topical application of 10% lidocaine in gel form to the painful skin of 11 patients with well established post-herpetic neuralgia (PHN). Pain decreased as measured by 100 mm VAS pain scale and 100 mm VAS pain relief scale in both trigeminal and thoracic PHN patients.

References

Jul 18, 1987·Lancet·V EsmannL Danielsen
Dec 26, 1987·Lancet·A C YoungG Young
Jul 1, 1985·Clinical Pharmacology and Therapeutics·G S LittmanB E Schneider
Mar 1, 1985·British Journal of Anaesthesia·B HallénA Uppfeldt
Aug 1, 1974·American Journal of Diseases of Children·H M LubensR M Reece
Jan 1, 1969·The Journal of Investigative Dermatology·S A Muller, R K Winkelmann
Jun 1, 1982·Neurology·C P WatsonJ Warsh
Dec 1, 1984·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·J NiamtuM S Garrett
Sep 1, 1982·Medicine·M W RagozzinoH O Perry
Dec 1, 1982·Acta Anaesthesiologica Scandinavica·G M Ehrenström Reiz, S L Reiz
Feb 1, 1957·A.M.A. Archives of Dermatology·J M DE MORAGAS, R R KIERLAND

❮ Previous
Next ❯

Citations

Jan 1, 1994·Annals of Neurology·M C Rowbotham
Feb 1, 1995·Annals of Neurology·M C RowbothamH L Fields
Aug 30, 2008·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·Joseph H FeinbergAlita Gonsalves
Sep 3, 2011·HSS Journal : the Musculoskeletal Journal of Hospital for Special Surgery·Joseph H Feinberg, Jeffrey Radecki
Jul 10, 2003·Obstetrics and Gynecology·Denniz A ZolnounJohn F Steege
May 1, 1994·Journal of the American Academy of Dermatology·J RiopelleM Naraghi
Jul 20, 1999·Journal of the American Academy of Dermatology·M L McCraryS K Tyring
Nov 1, 1996·Journal of Pain and Symptom Management·D Bowsher
Aug 26, 2006·Nature Clinical Practice. Neurology·Nanna B Finnerup, Troels S Jensen
Jul 1, 1998·International Journal of Dermatology·R BhargavaP Bhargava
Mar 30, 2001·International Journal of Dermatology·M W SugengG C Leok
Dec 13, 2006·Pain Practice : the Official Journal of World Institute of Pain·C Peter N Watson, Anne Louise Oaklander
Jul 4, 1996·The New England Journal of Medicine·R G Kost, S E Straus
May 20, 2000·Acta Neurologica Scandinavica. Supplementum·C Bonezzi, L Demartini
May 23, 2003·Anesthesia and Analgesia·Anna HadererGing Kuo Wang
Aug 17, 2002·Drugs & Aging·Rashmi BansalJeffrey M Weinberg
Dec 6, 2008·Hematology·M Cemalettin AksoyMumtaz Alpaslan
Dec 4, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lydia EstanislaoUNKNOWN Lidoderm-HIV Neuropathy Group
May 21, 2010·European Journal of Public Health·Karin Dam PetersenAllan Linneberg
Dec 16, 1998·Current Opinion in Neurology·M Koltzenburg
Aug 10, 2011·Physical Medicine and Rehabilitation Clinics of North America·Sanjog Pangarkar, Paul C Lee
Jun 1, 2000·Annals of Emergency Medicine·J Ducharme
Sep 27, 2003·Dermatologic Therapy·Jeffrey M Weinberg, Noah S Scheinfeld
Jan 1, 1997·Cancer Investigation·M M Hanania, D Brietstein
Mar 17, 2004·Dermatologic Clinics·Jeffrey M WeinbergNoah S Scheinfeld
Oct 10, 1998·Neurologic Clinics·B S Galer
Oct 10, 1998·Neurologic Clinics·R S Cluff, M C Rowbotham
Jun 5, 1999·International Endodontic Journal·E TidwellC D Ellis
Oct 30, 2013·The Cochrane Database of Systematic Reviews·Waqas KhaliqNaveen Kumar Puri
Mar 24, 2000·Drugs·A M Comer, H M Lamb
Jul 25, 2020·Current Pain and Headache Reports·Mariam Salisu OrhurhuVwaire Orhurhu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.